The Patent Finder

Aminopyrimidine/Pyrazine Derivatives as CTPS1 Inhibitors

Step Pharma S.A.S.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,371,419Aminopyrimidine/Pyrazine Derivatives as CTPS1 Inhibitors
In force
 · High confidence
Step Pharma S.A.SIn force
High confidence
US 11,987,573Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors
In force
 · High confidence
Sygnature Discovery LimitedIn force
High confidence
Application 19/217,739Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors
Pending
Not granted
Step Pharma S.A.S.PendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Step Pharma S.A.S..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited